Debiopharm Innovation Fund

company

About

Debiopharm Innovation Fund offers a strategic investments in for companies and businesses.

  • 1 - 10

Details

Industries
Venture Capital
Founded date
Jan 1, 1979
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

Debiopharm Innovation Fund invests in digital health companies that have an impact on cancer, infectious diseases, and drug development. We are looking for ambitious entrepreneurs raising series A or B with clinically proven, transformative technologies that use AI and data to help patients. We do not invest in consumer wellness or workflow solutions. Our initial investment is typically $2-5M. Along with capital we bring deep pharma knowledge & networks and long-term commitment to help build value in your company. We are an evergreen investment fund of the pharmaceutical company Debiopharm based in Lausanne, Switzerland.

Investments

Number of Investments
Number of Lead Investments
3
2
Debiopharm Innovation Fund has made 3 investments. Their most recent investment was on Dec 18, 2019, when BC Platforms raised $15M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 18, 2019 BC Platforms
Series C $15M Analytics
May 9, 2017 BC Platforms
Series B $10M Analytics Yes
Jun 27, 2005 Neovacs
Series Unknown Biotechnology Yes